MedTrace Logo

Feature Detection Study for Validation of Hamamatsu NanoZoomer S360MD Digital Slide Scanner System

NCT03992768 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 540

Last updated 2022-12-22

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate the repeatability and reproducibility of detection of histological features using whole slide imaging

Conditions

  • Pathology

Interventions

DEVICE

Hamamatsu NanoZoomer S360MD Digital Slide Scanner System

Detection of pathology features using whole slide imaging

Sponsors & Collaborators

  • Hamamatsu Photonics K.K.

    lead INDUSTRY

Principal Investigators

  • Anil Parwani, MD · Ohio State University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-12
Primary Completion
2021-09-30
Completion
2021-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03992768 on ClinicalTrials.gov